I think the board has most likely gone back to the 3 large international pharma companies that had started due diligence back in 2011 and they have advised us to make the changes that we have currently been doing before a deal can happen.
One of the big reasons they never did a deal was because we didn't own the IP.
Just my thoughts.
I think the board has most likely gone back to the 3 large...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
